NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity

CANNANNEW REPORT

Vancouver, B.C. – March 11, 2021: NeonMind Biosciences Inc. (CSE: NEON) (OTC: NMDBF) (FRA: 6UF) (“NeonMind”) is pleased to announce… Read More….. The post NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.